StockNews.com Upgrades Jazz Pharmaceuticals (NASDAQ:JAZZ) to

Jazz Pharmaceuticals (NASDAQ:JAZZ – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a note issued to investors on Friday. JAZZ has been the subject of a number of other reports. Stifel Nicolaus upped their price target on shares of Jazz Pharmaceuticals from $225.00 to […]

Related Keywords

Canada , United States , Patricia Carr , Neenam Patil , Stifel Nicolaus , Jazz Pharmaceuticals Company Profile , Jazz Pharmaceuticals Trading Down , News Ratings For Jazz Pharmaceuticals Daily , Covestor Ltd , Barclays , Royal Bank , Cantor Fitzgerald , Jazz Pharmaceuticals , Institutional Investors Weigh In On Jazz Pharmaceuticals , Insider Transactions At Jazz Pharmaceuticals , Rise Advisors , Analyst Recommendations For Jazz Pharmaceuticals , Cape Investment Advisory Inc , Get Free Report , Pharmaceuticals Trading Down , Investment Advisory , Wealth Management , Jazz Pharmaceuticals Daily ,